Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market
Holding SNTI?
Track your performance easily

Senti Biosciences (SNTI) Income Statement

94 Followers

Senti Biosciences Income Statement

Last quarter (Q2 2024), Senti Biosciences's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q2, Senti Biosciences's net income was $-11.20M. See Senti Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
$ 338.00K$ 1.98M$ 3.29M-
Cost of Revenue
----
Gross Profit
$ 838.00K$ 1.98M$ 3.29M-
Operating Expense
$ 83.25M$ 95.29M$ -74.92M$ 3.87M
Operating Income
$ -82.42M$ -92.73M$ -71.63M$ -3.87M
Net Non Operating Interest Income Expense
$ 1.58M$ 2.86M$ 1.70M-
Other Income Expense
$ -75.00K$ -19.50M$ -11.76M$ -8.78K
Pretax Income
$ -75.98M$ -83.41M$ -58.17M$ -3.86M
Tax Provision
----
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -56.99M$ -71.06M$ -58.17M$ -3.86M
Basic EPS
$ -5.33$ -1.60$ -2.23-
Diluted EPS
$ -5.33$ -1.60$ -2.23$ -0.34
Basic Average Shares
$ 139.42M$ 44.37M$ 26.11M$ 22.29M
Diluted Average Shares
$ 139.42M$ 44.37M$ 26.11M-
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 83.25M$ 95.29M$ -74.92M$ 3.87M
Net Income From Continuing And Discontinued Operation
$ -56.95M$ -71.06M$ -58.17M$ -3.86M
Normalized Income
$ -39.27M$ -40.14M--
Interest Expense
----
EBIT
$ -75.65M$ -83.41M$ -58.17M$ -3.86M
EBITDA
$ -69.53M$ -77.98M$ -54.60M$ -3.86M
Currency in USD

Senti Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis